Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Michael D. Farwell, MD

Michael D. Farwell, MD Physician

Assistant Professor of Radiology at the Hospital of the University of Pennsylvania

Dr. Farwell is employed by Penn Medicine.

Request an Appointment
No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.
X

Clinical Specialties

Specialty:

  • Radiology

Programs & Centers:

Board Certification:

  • Diagnostic Radiology, 2012
  • Nuclear Medicine, 2013

Clinical Expertise:

  • Clinical Molecular Imaging
  • Positron Emission Tomography / Computed Tomography (PET/CT)
  • Radioactive Iodine (Radioiodine) Therapy
  • Single-Photon Emission Computed Tomography (SPECT/CT)

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Amerihealth
  • NJ Medicaid
  • NJ Medicare
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Vetrans Choice Program (6/2018 Not Active)

Education and Training

Medical School: Columbia University
Residency: Saint Luke's-Roosevelt Hospital Center
Residency: NewYork-Presbyterian/Columbia University Medical Center
Fellowship: NewYork-Presbyterian/Columbia University Medical Center

Memberships

ECOG-ACRIN Biomarker Sciences Program, Imaging Liaison, National ECOG-ACRIN Melanoma Committee, Imaging Liaison, National Radiological Society of North America (RSNA), International Society of Nuclear Medicine and Molecular Imaging (SNMMI), International World Molecular Imaging Society (WMIS) Publication Committee, International

Hospital Affiliation

Dr. Farwell is employed by Penn Medicine.

Hospital Privileges:

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Selected Publications:

Chen X, Yang Y, Berger I, Khalid U, Patel A, Cai J, Farwell MD, Langer C, Aggarwal C, Albelda SM, Katz SI: Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging. Oncotarget 8 (15): 24213-24223,2017.

Lameka K, Farwell MD, Ichise M: Positron Emission Tomography. Handb Clin Neurol. 135 : 209-227,2016.

Mankoff DA, Edmonds CE, Farwell MD, Pryma DA: Development of Companion Diagnostics. Semin Nucl Med. 46 (1): 47-56,2016.

Shah NN, Torigian DA, Farwell MD, Hwang WT, Frey NV, Nasta S, Landsburg DJ, Mato AR, June CH, Schuster SJ, Porter DL, Svoboda J: Utility of FDG-PET/CT in lymphoma patients undergoing immunotherapy with autologous CTL019 T-cells. J Clin Oncol. ASCO annual meeting : 2015.

Mankoff DA, Farwell MD, Clark AS, Pryma DA: How imaging can impact clinical trial design: molecular imaging as a biomarker for targeted cancer therapy. Cancer J. 21 (3): 218-224,2015.

Farwell MD, Clark AS, Mankoff DA: How imaging biomarkers can inform clinical trials and clinical practice in the era of targeted cancer therapy. JAMA Oncology 1 (4): 421-422,2015.

Farwell MD, Pryma DA, Mankoff DA: PET/CT imaging in cancer: Current applications and future directions. Cancer 120 (22): 3433-3445,2014.

Farwell MD, Chong DJ, Iida Y, Bae SA, Easwaramoorthy B, Ichise M: Imaging P-glycoprotein function in rats using [(11)C]-N-desmethyl-loperamide. Ann Nucl Med. 27 (7): 618-624,2013.

Harris PE, Farwell MD, Ichise M: PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [18F]FP-DTBZ in baboons. Nucl Med Biol. 40 (1): 60-64,2013.

Academic Contact Info

Hospital of the University of Pennsylvania
Department of Radiology
Division of Nuclear Medicine and Clinical Molecular Imaging
3400 Spruce Street

Philadelphia, PA 19104
Phone: (215) 662-7750
Patient appointments: 800-789-7366 (PENN)